@article{F Angrilli_E Pennese_A Di Marzio_E Liberatore_R Di Lorenzo_G Fioritoni_2002, place={Pavia, Italy}, title={A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin’s lymphoma}, volume={87}, url={https://haematologica.org/article/view/2559}, DOI={10.3324/%x}, abstractNote={We treated 30 consecutive untreated patients aged > 70 years with advanced aggressive non-Hodgkin’s lymphoma with 6 courses of cyclophosphamide, mitoxantrone, etoposide, bleomycin, vinblastine and dexamethasone (D-VICEMB). The global response was 93%. The 6-year overall survival and progression-free survival were 50%, and disease-free survival was 63%.}, number={11}, journal={Haematologica}, author={F Angrilli and E Pennese and A Di Marzio and E Liberatore and R Di Lorenzo and G Fioritoni}, year={2002}, month={Nov.}, pages={1227-1229} }